E2086
E2086 is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
A Study of E2086 in Healthy Adult Participants
Clinical Trials (6)
A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
A Study of E2086 in Healthy Adult Participants
A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6